Biological Material Transfer Agreement Template for the United States

A Biological Material Transfer Agreement (MTA) is a legally binding contract that governs the transfer of biological materials between research institutions, universities, and organizations in the United States. This agreement establishes the terms and conditions under which biological materials such as cell lines, plasmids, antibodies, transgenic animals, pathogens, or genetic constructs are shared for research, development, or commercial purposes.

When do you need this document?

You need an MTA whenever biological materials cross organizational boundaries for research or commercial purposes. This includes transfers between universities and pharmaceutical companies for drug development, sharing of transgenic mouse models between research institutions, or providing cell lines to collaborating laboratories. The agreement is essential when transferring materials that may have commercial potential, contain proprietary modifications, or involve select agents regulated by federal agencies. Academic institutions typically require MTAs for any outgoing biological materials to protect their intellectual property rights and ensure proper attribution in resulting publications.

Key legal considerations

The agreement must clearly define the scope of permitted uses and explicitly prohibit unauthorized commercial applications or redistribution to third parties. Intellectual property provisions should address ownership of derivative materials and modifications created by the recipient. Publication rights clauses ensure proper attribution while protecting confidential information. Liability and indemnification sections allocate responsibility for potential damages, safety incidents, or regulatory violations. The agreement should include termination provisions that require return or destruction of materials upon contract expiration. Compliance obligations must address biosafety protocols, personnel training requirements, and proper disposal methods for biological waste.

Legal requirements in United States

Federal regulations significantly impact MTA terms and enforceability. NIH Guidelines for Research Involving Recombinant DNA Molecules mandate specific containment and safety protocols for genetic materials. CDC Select Agent Regulations under 42 CFR Part 73 impose strict registration, security, and transfer requirements for dangerous pathogens and toxins. USDA regulations govern agricultural biological materials including plant and animal pathogens. Export control laws (EAR and ITAR) restrict international transfers of certain biological materials and associated technical data. The Biosafety in Microbiological and Biomedical Laboratories (BMBL) guidelines establish standard safety practices that must be incorporated into handling protocols. Institutional Review Board approval may be required for materials derived from human subjects, and IACUC approval is necessary for animal-derived materials.